Carl Zeiss Meditec wins FDA clearance for CLINIC 360 ahead of US ophthalmology launch
ZEISS CLINIC 360 can consolidate ophthalmic images, diagnostic information and glaucoma progression analysis in a browser-based Class II medical device.
ZEISS CLINIC 360 can consolidate ophthalmic images, diagnostic information and glaucoma progression analysis in a browser-based Class II medical device.
FDA Premarket Approval gives Implantica a US launch pathway for RefluxStop after long-term clinical evidence tested an implant that avoids encircling the esophagus.
New Day Skin Spray uses a silk fibroin-containing barrier formulation and reached the US market through FDA’s 510(k) medical-device pathway rather than drug approval.
FDA Fast Track designation could increase regulatory interaction around safusidenib while Nuvation Bio tests the IDH1 inhibitor across several glioma settings.
FDA authorizes Vitestro’s Aletta robotic blood draw device via De Novo. See how its clinical data could reshape outpatient phlebotomy.